It has been suggested that cytoplasmic cyclin D1 is more common in colorectal tumours deficient for β-catenin (Kuramochi et al, 2006); however, β–catenin has been shown to regulate cyclin D1 expression in colon cancer cells (Tetsu and McCormick, 1999). Here, CCND1 is linked to malignant colon neoplasm.